Cargando…
Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression
Liraglutide, a glucagon-like peptide-1 analog, has been proved to reduce body weight and visceral adipose tissue (VAT) in human studies. In this study, we aimed at examining lipogenetic signal changes in VAT after weight-loss with liraglutide in db/db mice. The mice were divided into two groups: lir...
Autores principales: | Shao, Yimin, Yuan, Geheng, Zhang, Junqing, Guo, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342181/ https://www.ncbi.nlm.nih.gov/pubmed/25733821 http://dx.doi.org/10.2147/DDDT.S79175 |
Ejemplares similares
-
Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention
por: Cheng, Fangxiao, et al.
Publicado: (2019) -
Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice
por: Song, Ji-Xian, et al.
Publicado: (2022) -
Antidiabetic Effect of Artemether in Db/Db Mice Involves Regulation of AMPK and PI3K/Akt Pathways
por: Bai, Xiaolin, et al.
Publicado: (2020) -
Effects of liraglutide on astrocyte polarization and neuroinflammation in db/db mice: focus on iron overload and oxidative stress
por: An, Ji-Ren, et al.
Publicado: (2023) -
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
por: Luo, Li, et al.
Publicado: (2019)